Van T. Mitchell, Chair (chosen by Senate President & House Speaker)
Appointed by Governor: Joseph F. Levy, Ph.D.
Appointed by Senate President: Renee C. Bovelle, M.D.
Appointed by House Speaker: Eberechukwu Onukwugha, Ph.D.
Appointed by Attorney General: Gerard F. Anderson
Andrew York, J.D., Pharm.D., Executive Director
Maryland Prescription Drug Affordability Board
16900 Science Drive, Suite 112-114, Bowie MD, 20715
(410) 804-0251; fax: (443) 213-0187
e-mail: andrew.york@maryland.gov
web: https://pdab.maryland.gov/index.html
POLICY & SPECIAL PROJECTS
Kris Vallecillo, J.D., Manager (410) 804-0413
e-mail: kris.vallecillo3@maryland.gov
In July 2019, the Prescription Drug Affordability Board was authorized by the General Assembly (Chapter 692, Acts of 2019).
In conjunction with the Prescription Drug Affordability Stakeholder Council, the Board identifies circumstances under which the cost of a prescription drug product may create or has created affordability challenges for the State health care system and patients; and establishes criteria that the Board will use to set an upper payment limit for a prescription drug product after considering certain factors (Code Health-General Article, sec. 21-2C-01 through 21-2C-15).
The Board consists of five members and five alternate members appointed to five-year terms (Code Health-General Article, sec. 21-2C-03).
Appointed by Governor to 3-year terms: Babette S. Edgar, Pharm.D., 2023; John Elliott, 2023; Barry N. Lipsy, 2024; Kimberly Y. Robinson, Esq., 2023; Hayley Y. Park, Pharm.D., 2024; Martin P. Rosendale, 2024; Greta Engle Kessler, 2025; Beth Rada, 2025; Joseph Winn, 2025.
Appointed by Senate President to 3-year terms: Sherita Hill Golden, M.D.; James Gutman; Eric Morse, D.D.S.; Marc L. Nicole; Nicole Stallings, M.D.; Lorraine R. Diana, N.P., 2025; Deron Johnson, 2025; Stephen Rockower, M.D., 2025; one vacancy.
Appointed by House Speaker to 3-year terms: Jacqueline Boone Allsup; Shawn Brown; Allison Ciborowski; Shaun O’Brien; Mandi Poplawski; Glenn Schneider; Sean Tunis; Thea Williams.
Formed by the General Assembly in July 2019, the Prescription Drug Affordability Stakeholder Council serves as an advisory board to the Prescription Drug Affordability Board (Chapter 692, Acts of 2019).
Twenty-six members constitute the Council. Nine are appointed by the Governor, nine by the Senate President, and eight by the House Speaker. All serve three-year terms (Code Health - General Article, sec. 21-2C-04).
Search the Manual
PRESCRIPTION DRUG AFFORDABILITY STAKEHOLDER COUNCIL
Vacancy, Co-Chair (chosen by Chair, Prescription Drug Affordability Board)
Vacancy, Co-Chair (chosen by Chair, Prescription Drug Affordability Board)
Maryland Constitutional Offices & Agencies
Maryland Departments
Maryland Independent Agencies
Maryland Executive Commissions, Committees, Task Forces, & Advisory Boards
Maryland Universities & Colleges
Maryland Counties
Maryland Municipalities
Maryland at a Glance
Maryland Manual On-Line
e-mail: mdmanual@maryland.gov
|
|| Search the Archives || Education & Outreach || Archives of Maryland Online ] Governor General Assembly Judiciary Maryland.Gov
|